17:36 , Nov 2, 2017 |  BC Extra  |  Company News

Management tracks: Melinta, Lundbeck

Infectious disease company Melinta Therapeutics Inc. (New Haven, Conn.) hired Dan Wechsler as president and CEO and John Bluth as EVP of investor relations and corporate communications. Wechsler was operating partner at Welsh, Carson, Anderson...
07:00 , Jul 11, 2016 |  BC Week In Review  |  Financial News

Aprecia completes venture financing

Aprecia Pharmaceuticals Co. , Langhorne, Pa.   Business: Drug delivery, Neurology   Date completed: 2016-07-05   Type: Venture financing   Raised: $20 million   Investor: Hercules Capital   Note: Aprecia drew down $20 million of...
08:00 , Feb 1, 2016 |  BC Week In Review  |  Financial News

Aprecia completes venture financing

Aprecia Pharmaceuticals Co. , Langhorne, Pa.   Business: Drug delivery, Neurology   Date completed: 2016-01-27   Type: Venture financing   Raised: $35 million   Investors: Deerfield Management; JW Asset Management LLC   Note: The financing...
07:00 , Aug 10, 2015 |  BC Week In Review  |  Clinical News

Levetiracetam regulatory update

FDA approved an NDA from Aprecia for Spritam levetiracetam as an adjunct treatment of seizures in epileptics. Spritam is indicated for partial-onset seizures in patients ages >=4 and weighing > 20kg; myoclonic seizures in patients...
08:00 , Nov 18, 2013 |  BC Week In Review  |  Company News

Aprecia management update

Aprecia Pharmaceuticals Co. , Langhorne, Pa.   Business: Drug delivery   Hired: Don Wetherhold as CEO, formerly SVP of long-term care at Omnicare Inc.  ...